Lilly looks to double pipeline size again

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. pounded its chest a couple years ago after doubling the size of its drug pipeline to 60 molecules. Now, the company thinks it has developed a creative way to double it again in the next five years.

Indianapolis-based Lilly is developing what it calls “The Mirror Portfolio,” which it expects to grow to 45 to 60 drugs in five years. This month, Lilly announced it had secured venture-capital funding for the first two drugs in this alternative pipeline.

Lilly has committed to invest up to $150 million in three unnamed venture-capital funds, providing no more than 20 percent of the dollars the funds would use to invest in the development of early-stage drug molecules. That means Lilly eventually could have $750 million at its disposal to fund development of experimental drugs.

That pot of cash could give Lilly more resources to help develop molecules that its own scientists discover. But even more valuable, the money could give Lilly a peek at promising drugs being developed by academic researchers much earlier in the development process.

“We actually are seeing innovation opportunities that may not have come to us at this stage,” said Rob Armstrong, Lilly’s vice president of global research and development, and the architect of the Mirror Portfolio.

In this month’s deal, one of the venture firms acquired two molecules from the Mirror Portfolio—one of which was a Lilly-developed drug and one of which was from an academic institution, which Armstrong declined to name. The Lilly drug is being studied as a bone and cancer treatment. The academic drug is designed to treat congestive heart failure.

The venture-capital firm will oversee the drugs’ development, but it has chosen to contract with a Lilly subsidiary called Chorus to try to prove whether the drugs work as their researchers think they will. Such proof-of-concept studies typically take about three years.

Lilly will have first right-of-refusal to buy its drug back from the venture-capital firm. For the academic drug, it can either negotiate for that right or else be one bidder among many seeking to acquire the drug.

“This allows us to share some risk,” Armstrong said, adding, “What we’ve been able to do is provide a little bit of insight even for the venture fund about what  commercial potential a molecule may have.”

Lilly also has cloned its Chorus team, which has developed faster, more efficient ways to conduct proof-of-concept studies on early-stage molecules. There will now be a second Chorus team in Indianapolis called Chorus Resonance, as well as teams in the United Kingdom and India.

Investor Jason Chew, blogging about Lilly's Mirror Portfolio at Seeking Alpha.com, said he’s skeptical about Lilly’s strategy to reinvent its R&D model.

“The company boasts over 60 compounds in its pipeline, but has been beset lately by late-stage failures,” wrote Chew, who does not own any Lilly stock. “It hopes to begin gaining two approvals per year beginning in 2013 to dig itself out of its hole. This would be quite a feat, considering only 21 new drugs were approved by the FDA in all of 2010. Perhaps it’s time to turn away from 'innovating on innovation' and simply go back to conducting research. Perhaps cheap and fast drug development is but an illusion.”


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. Good Day I am Mr (Victoria Wright) from United state of America, i stayed in NEW YORK, and i have a broke up business, until i found this company email who help me to gain a loan for business,, and now i want to used this short medium to congratulate the below company for the fast and safe money they loan to me without any form of collateral, i loan 500,000USD from the company to save my business and lots more, i saw their mail on the internet, everyone always give testimony for what they did, so i quickly contacted them and they all did everything for me without stress and my money was sent to my account just 3 days later, i was surprise and i feel so glad, now i have a standard business control agent who help me, now i will advice those who need urgent loan to contact him at the bellow email:zenithfirm12@gmail.com

  2. NOTICE:This is to inform the general public that Vampires are real. My name is James Franklyn.,am an agent of vampire,am here to introduce our new world trend to you,a world of vampire where life get easier,we have made so many persons vampires and have turned them rich,you will be assured long life and prosperity,you shall be made to be very sensitive to mental alertness,stronger and also very fast,you will not be restricted to walking at night only even at the very middle of broad day light you will be made to walk.In case you are wildly oppressed by some unscrupulous persons we can still help you fight them.Your protection is assured immediately you join.Just contact the bellow email if you are interested we are here to attend to you anytime you want us. Contact the bellow email for more details. Email:vampirescreed@hotmail.com Sincerely: James Franklyn.

  3. Bravo! Someone else that is willing to speak the truth! Bravo!_____NBCSN is available in almost 2 MILLION more homes than just a few years ago, but Indycar STILL gets less total viewers than it did just a few years ago when NBC took over Versus. Attendance and ratings cratered with the end of season races (just when the title battle got "interesting" HAH!__________And now...new race in Basilia, where Miles celebrated the "rich history" of Indycar racing there. Rich history? What, 7 events in the 100 years of AOW? Yep, some history. Well, at least its an oval. It's not??? Are you kidding me??? Gosh darn road racin furriners.

  4. PURITY RAY LOAN OFFER........ Have you been denied by your banks,or are you in need of of an urgent loan to pay of your bills we are capable of giving loans @ cheaper rate to interested individuals, student, companies and members of the public in need of finance to settle bills, we do offer considerable loans which you can count on. For more information on our various types of loan,then you will have to contact PURITY RAY LOAN FIRM, to help you achieve your desire LOAN APPLICATION FORM TO BE FILLED BORROWERS INFORMATION * Full name:………………………. * SEX * ……………………………. * Country………………………….. * State:……………………………. * Land:…………………………….. * Occupation:…………………….. * phone number:…………………. * Telephone: ………………………….. * Age:………………………………. * Amount needed as loan:……… * Loan Duration:………………….. * Propose of Loan:……………….. * Annual revenue:………………… * Monthly Income:……………….. * Guarantee:………………………. * Payment: monthly or annually Email.....purityrayloanfirm@gmail.com Thank you and God bless Mr Purity Ray PURITY RAY LOAN FIRM we tend to serve you better

  5. Problem: most of the people responding to this article don't know about this service AT ALL! Why? Lack of awareness. This isn't IndyGo. This is CIRTA: might as well be the mattress company because they are asleep at the wheel - something like 3 directors over the last year? Playing with federal grant money is great! This "region" wants commuter rail service, has spent MILLIONS on Transportation studies yet can't even support a commuter bus line? This is largely for suburban riders to get to downtown - not for "service people to work in our hotels and restaurants" ! Get your head out of your backside!! These are professionals, students etc. that don't want to fight traffic, save some money on parking, gas, stress.... if CIRTA would put their federal money into widely promoting the sevive to Greenwood, Fishers & Carmel instead of finding directors and studies - this would be a successful service. Our family uses(d) it daily for the last several years - but the recent uncertainty & now unreliability due to cuts from Carmel has been a problem. Now, costs us an additional $350/month for gas & parking ( $4200/year) plus vehicle wear, service, environmental impact ... YES - this REGION needs this this type of service in order to keep growing and getting the people it needs to fill skilled positions in downtown Indianapolis. Think outside of your own car !!!